Trading Window

BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED CIN: L24233MP1985PLC002709 Registered Office: B/12-B, Industrial Estate, Pologround, Indore-452015 (M.P.) Tel. 0731-2426700; Email id- bcplcompliance@gmail.com; Website- www.biofilgroup.net; Fax: 0731-2426700 Date: 25th June, 2026 To, To, The Secretary (DCS/Compliance), The Secretary (Listing/Compliance), Corporate Relationship Department, National Stock Exchange of India Limited, BSE Limited (DCS/Compliance) Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Mumbai – 400051 Dalal Street, Mumbai-400001 SUBJECT: INTIMATION OF CLOSURE OF TRADING WINDOW REF: BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED (BSE SCRIP CODE 524396; NSE SYMBOL: BIOFILCHEM; ISIN: INE829A01014) Dear Sir/Madam, This is with reference to the BSE Circular Ref No. LIST/COMP/01/2019-20 and NSE Circular Ref No. NSE/CML/2019/11 dated 02.04.2019, we wish to inform you that in terms of the Company's Code of Conduct to regulate, monitor and report trading in Company's Securities by Insiders framed under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company shall remain closed for all Designated Persons, their immediate relatives and connected persons (as defined in the Code) w.e.f. Wednesday, July 01, 2026 for the purpose of consideration of Un-Audited Financial Results for the quarter ended June 30, 2026. This is further informed that the Company has also complied with the requirements of Securities and Exchange Board of India (SEBI) Circular No. SEBI/HO/ISD/ISD-SEC-4/P/CIR/2022/107 dated August 5, 2022, SEBI/HO/ISD/ISD-PoD-2/P/CIR/2023/124 dated July 19, 2023 and SEBI/HO/ISD/ISD-PoD- 2/P/CIR/2025/55 dated April 21, 2025 regarding Trading Window Closure period under Clause 4 of Schedule B read with Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”) framework for restricting trading by Designated Persons (“DPs”) by freezing PAN at security level. The Trading Window shall open 48 hours after the Un-Audited Financial Results for the quarter ended June 30, 2026 become generally available i.e. declaration of these Results to the Stock Exchanges. All the Directors, KMP’s, Designated Employees, Connected Persons, Fiduciaries and their immediate relatives are advised not to deal in the securities of the Company either directly or indirectly during the aforesaid period. Further, we are submitting the above said information in XBRL mode (excel template provided by Exchange) along with the submission in PDF mode within prescribed time limit. The date of Board Meeting for the purpose of consideration of Un-Audited Financial Results for the quarter ended June 30, 2026, will be intimated in due course. This is for your information and further dissemination. Thanking you, Yours Faithfully, FOR BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED APOORV JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. NO. A71739